|
|
||||||||
Ann Thorac Surg 1997;64:37-42
© 1997 The Society of Thoracic Surgeons
Division of Pediatric Cardiothoracic Surgery, Department of Anesthesiology, and Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
| Abstract |
|---|
|
|
|---|
Methods. From January 1995 to June 1996, 120 consecutive cavopulmonary operations were performed at The Children's Hospital of Philadelphia. Procedures included lateral tunnel fenestrated Fontan (n = 50), extracardiac Fontan (n = 5), hemi-Fontan (n = 60), and bidirectional Glenn shunt (n = 5). Modified ultrafiltration was performed after cardiopulmonary bypass in 41 patients, and results were compared by t test with a control group of 79 patients in whom modified ultrafiltration was not used.
Results. There was one death for an operative (30-day) mortality of 0.8%. Age, weight, diagnosis, ischemic arrest time, and cardiopulmonary bypass time were similar between the modified ultrafiltration and control groups. Postoperative blood use, chest tube output, the incidence of pleural and pericardial effusions, and hospital stay were all significantly decreased when modified ultrafiltration was used.
Conclusions. By lowering the perioperative morbidity of staged cavopulmonary operations, modified ultrafiltration makes an important contribution to improving outcome after the correction of single-ventricle cardiac anomalies.
| Introduction |
|---|
|
|
|---|
Since the introduction of right-heart bypass in the management of single-ventricle cardiac anomalies, a number of modifications have been introduced to reduce the morbidity and mortality of these operations. The lateral tunnel method of total cavopulmonary connection, a staged surgical approach using a superior cavopulmonary connection before the modified Fontan repair, and fenestration of the intraatrial baffle have led to improved operative outcomes [14]. As operative mortality rates for this approach decrease, attention now shifts to reducing the perioperative and long-term morbidity of these operations.
A number of adverse effects are associated with the use of cardiopulmonary bypass in children [5]. There is an increase in capillary permeability that leads to an overall increase in total body water and edema formation. Hemodilution occurs due to the large priming volumes of the cardiopulmonary bypass circuit. Pulmonary compliance and gas transfer are decreased, and myocardial edema may result in diastolic dysfunction. Efforts to reduce the deleterious effects of postbypass capillary leak syndrome include optimizing bypass and cooling techniques, reducing circuit volumes, perioperative antiinflammatory and diuretic therapies, and the use of postoperative peritoneal dialysis. In 1991, Naik and associates [6] introduced the technique of modified ultrafiltration (MUF) as an alternative method to reduce the adverse effects of cardiopulmonary bypass in pediatric patients.
The technique of MUF is performed after cardiopulmonary bypass is completed and allows ultrafiltration of both the patient and the remaining contents of the venous reservoir. In addition to plasma water, solutes less than 50 kilodaltons in size are removed, including a number of inflammatory mediators [7]. Early studies with modified ultrafiltration reported decreases in the accumulation of total body water that occurs after cardiopulmonary bypass, reduced perioperative blood loss, and decreased blood use [6]. Later studies demonstrated improvements in myocardial function and cerebral oxygenation after circulatory arrest [8, 9]. Postbypass pulmonary vascular resistance also appears to be reduced using MUF [8].
Children after the repair of single-ventricle anomalies are particularly sensitive to elevations in pulmonary vascular resistance and decreases in pulmonary and ventricular compliance. We addressed the use of MUF in these children, specifically after cavopulmonary operations. The hypothesis of this study is that the use of MUF after cardiopulmonary bypass improves early outcome after the staged repair of single-ventricle anomalies.
| Material and Methods |
|---|
|
|
|---|
Operations to revise previous Fontan repairs such as hepatic vein inclusion and baffle fenestration were not included in this series.
Hypoplastic left heart syndrome was the most common cardiac anomaly in this series, and 55 of the 120 procedures (46%) were for anatomic variations of this defect (Table 1
). Other common diagnoses included complex forms of double-outlet right ventricle, tricuspid atresia, complex transposition of the great arteries, single ventricle, and heterotaxy syndromes.
|
| Operative Technique |
|---|
|
|
|---|
The majority of these operations (91%) were performed with the use of circulatory arrest. All bidirectional Glenn shunts were performed using cardiopulmonary bypass alone. A few Fontan repairs were also performed on cardiopulmonary bypass, without the use of circulatory arrest. The median circulatory arrest time was 32 minutes, and arrest time ranged from 15 to 73 minutes. Cardiopulmonary bypass time, including the circulatory arrest period, had a median of 67 minutes and ranged from 22 to 147 minutes.
Modified ultrafiltration was performed after cardiopulmonary bypass in 41 of the 120 operations in this series (34%). We began using MUF routinely at The Children's Hospital of Philadelphia in October 1995, and its use was related to surgeon preference. Although two of the surgeons had patients in both the MUF and the control groups, one surgeon did not use MUF. The technique of MUF was described in detail previously by Elliott [8]. The MUF was generally performed over 15 to 20 minutes after the discontinuation of cardiopulmonary bypass. There were no significant complications associated with the ultrafiltration procedure.
Fresh whole blood was used for perioperative transfusion when necessary. Whole blood was also added to the cardiopulmonary bypass prime if needed to maintain a hematocrit between 18% and 20% while on bypass. Blood use was calculated for each patient by the sum of the blood given to the patient in the operating room (exclusive of the pump prime) and the amount given in the intensive care unit during the first 24 hours after the operation. Because of variations in patient size, this value was normalized for patient weight, and expressed as milliliters per kilogram per 24 hours. Clotting factors (fresh frozen plasma, cryoprecipitate, and platelets) were infrequently used, but were also calculated into the blood use. Perioperative blood loss was calculated from the chest tube drainage in the first 24 hours after the operation, and was also expressed as milliliters per kilogram per 24 hours.
| Assessment of Operative Outcome |
|---|
|
|
|---|
Early pleural and pericardial effusions occurred frequently in this series, especially after modified Fontan repair. Early pleural or pericardial effusions were defined in this study as those requiring drainage within 30 days of the operation. Our standard management protocol for pleural and pericardial effusions was as follows:
Usually effusions were treated conservatively with diuretics unless hemodynamic or pulmonary compromise occurred, or if the effusions were large or enlarging rapidly. Overall, 24 of the 120 patients (20%) required percutaneous drainage of pleural or pericardial effusions.
| Statistical Analysis |
|---|
|
|
|---|
| Results |
|---|
|
|
|---|
|
| Operative Outcome |
|---|
|
|
|---|
Mediastinal reexploration was required for bleeding in 6% of patients overall. The incidence of reexploration after MUF was 4.8%, whereas without MUF the incidence of reexploration was 6.4%. This difference was not statistically significant. An additional two reoperations were necessary in the control group to repair baffle leaks that occurred after hemi-Fontan procedures.
Perioperative blood use for each group is demonstrated in Figure 1
. The average amount of blood transfused per patient using MUF was 29 ± 4 mLkg-124 hours-1 (median, 25.6 mLkg-124 hours-1); the control group averaged 63 ± 4 mLkg-124 hours-1 (median, 56.8 mLkg-124 hours-1). This difference was significant with a p value less than 0.001. When the transfusion volume was not normalized for weight the difference remained significant. Ten percent (4 of 41) of patients in the MUF group did not require a blood transfusion during their hospitalization. In contrast, only 2.5% (2 of 79) of patients in the control group did not receive a transfusion.
|
|
|
There was a significant difference in the incidence of early postoperative pleural and pericardial effusions between the MUF and control groups. When MUF was used, 4.9% of patients undergoing cavopulmonary operations had pleural or pericardial effusions during their postoperative course that required drainage (Fig 4
). When MUF was used, 10.5% of patients required drainage of effusions after modified Fontan procedures, whereas no patients required drainage after superior cavopulmonary connection alone. Without the use of MUF in the control group the overall incidence of postoperative effusions requiring drainage was 28.2%. The incidence after superior cavopulmonary connection alone was 11.5%, whereas the incidence after modified Fontan repair was 48.5%. Each of these differences between the MUF and control groups was significant, with p values less than 0.01. Three patients, all of whom were in the control group, required reoperation for creation of a pericardial window due to persistent pericardial effusions.
|
| Comment |
|---|
|
|
|---|
Our current series represents a heterogeneous group of patients, the majority of whom were less than 3 years of age. Hypoplastic left heart syndrome and complex forms of double-outlet right ventricle (usually with mitral atresia) were the most common anomalies. Some consider these children to be high-risk Fontan candidates because of "unfavorable" atrioventricular valve anatomy [14]. Despite this, the overall operative mortality in this series was 0.8%. The operative mortality after modified Fontan repair was 1.8%, which is among the lowest reported for a series this size.
The hemi-Fontan repair was performed in half of the patients of this series. This type of superior cavopulmonary connection is advocated by some surgeons for the second stage of the surgical management of hypoplastic left heart syndrome, because the pulmonary arteries commonly may become distorted after the initial Norwood repair [10, 15, 16]. Nearly half of the children in this series had hypoplastic left heart syndrome, so this procedure was used frequently. In addition, a number of our patients underwent previous palliative operations that had distorted or narrowed the pulmonary arteries, such as pulmonary banding and systemicpulmonary shunting. Elevated pulmonary artery pressures and pulmonary artery distortion were both shown to be risk factors for poor outcome after Fontan repair [14, 17]. The use of the hemi-Fontan repair limited pulmonary artery distortion in our experience. Also, because superior vena cavaright atrial continuity is maintained using the hemi-Fontan repair, the completion Fontan stage may be technically easier and faster.
The frequent use of circulatory arrest in this series is also an indication of the complexity of our patient population. The majority of these patients had at least one previous median sternotomy, and many had two or three. Bicaval cannulation may be difficult in this situation, especially in those patients with hypoplastic left heart syndrome. This method of cannulation also risks distortion and thrombosis of the venae cavae, a potentially lethal complication after Fontan repair. The use of circulatory arrest allowed for shorter cardiopulmonary bypass times, thus reducing the potential for postoperative pulmonary dysfunction, which may be a serious problem after cavopulmonary connection. Circulatory arrest times were kept fairly short, and despite the frequent use of circulatory arrest in this series, neurologic complications were uncommon. Two patients had perioperative strokes with evidence of cerebral infarction on computed tomography of the head, and 2 patients required treatment for postoperative seizures. The overall neurologic complication rate was 3.6%. Although our institution is currently involved in studying the long-term neurologic effects of circulatory arrest in infants and children, we performed no in-depth postoperative neurologic testing in this series.
The original randomized series using MUF after cardiopulmonary bypass in children demonstrated significant decreases in postoperative blood loss and perioperative blood use [6]. In our series the postoperative blood loss using MUF was half the amount compared with a control group in which MUF was not used. The same was true for the volume of blood transfused. Although this was not a randomized series, our perioperative management practices remained relatively standard during the study period. There was also no significant difference in perioperative hematocrit levels between the two groups of patients, suggesting no difference in management techniques. The use of MUF in our current practice has allowed the majority of children who do not require blood for the bypass pump prime to go without a blood transfusion during their perioperative course.
The adverse effects of the postbypass capillary leak syndrome were generally not seen in this study. Although modified ultrafiltration reduces the accumulation in total body water seen after cardiopulmonary bypass, the patients in the control group of this study did not require more diuretic therapy or have greater problems with edema. However, the bypass times and circulatory arrest times in this study were relatively short: for most modified Fontan repairs the circulatory arrest time was less than 20 minutes, and the bypass time was less than 60 minutes. Shorter duration of bypass may result in less capillary leak, thereby attenuating the beneficial effects of MUF.
The decrease in the incidence of early postoperative pleural and pericardial effusions using MUF was an unexpected benefit of the use of this technique. Although the incidence of pleural effusions after modified Fontan repair in the control group was higher than in other series [18], it compared with previous studies from our institution [10, 16]. The vast majority of the modified Fontan procedures in each group were fenestrated lateral-tunnel repairs. The only exception were the five extracardiac Fontan repairs, which were necessary due to the patients' cardiac anatomy. In each of these patients a fenestration was performed as well. Because the etiology of postoperative effusions after cavopulmonary connection is still unknown, it is difficult to postulate a precise mechanism for the lower incidence seen using MUF. One possibility is the removal of circulating inflammatory mediators by the ultrafiltration process. Another possibility is that subtle increases in postbypass total body water that occur when MUF is not used are manifested several days after the operation as pleural and pericardial effusions. Although we did not examine hemodynamics in this study, myocardial edema and diastolic dysfunction may be more pronounced without MUF, leading to higher central venous pressures. Reducing the incidence of postoperative effusions using MUF in this series resulted in a significant reduction in postoperative hospital stay.
The major limitation of this study is that the use of MUF was not randomized. Performing MUF after cardiopulmonary bypass was related to surgeon preference in this series, although it was used fairly routinely after October 1995. Although the argument may be made that our control group then represents little more than a historical control, in fact the only modification made in the perioperative routine of these patients during the study period was the introduction of MUF. All other variables such as operative techniques, indications for transfusion, and criteria for drainage of pleural effusions remained constant. Other aspects of the patient population (preoperative and operative characteristics, see Tables 1 and 2![]()
) were virtually identical between the two groups. It is difficult, however, to exclude the surgeon as a variable in the differences shown in this study, because one of our surgeons did not use MUF. Nevertheless, when the results for the two other surgeons in this series were compared using a t test, perioperative blood use, blood loss, and the incidence of postoperative effusions were still significantly less using MUF.
In summary, MUF is a safe adjunct to the staged repair of complex single-ventricle cardiac anomalies. Perioperative blood loss and blood use were significantly decreased when MUF was used. There was a lower incidence of early postoperative pleural and pericardial effusions in patients who received MUF after cardiopulmonary bypass, and this resulted in a significantly shorter hospital stay. The overall operative mortality rate in this series of 0.8% is among the lowest reported for cavopulmonary operations in a patient population of this size and complexity.
|
| Acknowledgments |
|---|
|
|
|---|
| Footnotes |
|---|
|
|
|---|
Address reprint requests to Dr Spray, Division of Pediatric Cardiothoracic Surgery, The Children's Hospital of Philadelphia, 34th St and Civic Center Blvd, Philadelphia, PA 19104.
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
J. A. Feinstein, D. W. Benson, A. M. Dubin, M. S. Cohen, D. M. Maxey, W. T. Mahle, E. Pahl, J. Villafane, A. B. Bhatt, L. F. Peng, et al. Hypoplastic left heart syndrome current considerations and expectations. J. Am. Coll. Cardiol., January 3, 2012; 59(1 Suppl): S1 - S42. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Cooper, J. R. Charpie, F. X. Flores, J. William Gaynor, J. W. Salvin, P. Devarajan, and C. D. Krawczeski Acute Kidney Injury and Critical Cardiac Disease World Journal for Pediatric and Congenital Heart Surgery, July 1, 2011; 2(3): 411 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shinkawa, P. V. Anagnostopoulos, N. C. Johnson, L. Presnell, N. Watanabe, A. Sapru, and A. Azakie Early Results of the "Clamp and Sew" Fontan Procedure Without the Use of Circulatory Support Ann. Thorac. Surg., May 1, 2011; 91(5): 1453 - 1459. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yokoyama, S. Takabayashi, T. Komada, K. Onoda, Y. Mitani, H. Iwata, and H. Shimpo Removal of prostaglandin E2 and increased intraoperative blood pressure during modified ultrafiltration in pediatric cardiac surgery. J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 730 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schreiber, J. Horer, M. Vogt, J. Cleuziou, Z. Prodan, and R. Lange Nonfenestrated Extracardiac Total Cavopulmonary Connection in 132 Consecutive Patients Ann. Thorac. Surg., September 1, 2007; 84(3): 894 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G Raja, S. Yousufuddin, F. Rasool, A. Nubi, M. Danton, and J. Pollock Impact of modified ultrafiltration on morbidity after pediatric cardiac surgery. Asian Cardiovasc Thorac Ann, August 1, 2006; 14(4): 341 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pizarro, T. Mroczek, S. S. Gidding, J. D. Murphy, and W. I. Norwood Fontan Completion in Infants Ann. Thorac. Surg., June 1, 2006; 81(6): 2243 - 2249. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G Raja and G. D Dreyfus Modulation of Systemic Inflammatory Response after Cardiac Surgery Asian Cardiovasc Thorac Ann, December 1, 2005; 13(4): 382 - 395. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gupta, C. Daggett, S. Behera, M. Ferraro, W. Wells, and V. Starnes Risk factors for persistent pleural effusions after the extracardiac Fontan procedure J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1664 - 1669. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Berdat, E. Eichenberger, J. Ebell, J.-P. Pfammatter, M. Pavlovic, C. Zobrist, E. Gygax, U. Nydegger, and T. Carrel Elimination of proinflammatory cytokines in pediatric cardiac surgery: Analysis of ultrafiltration method and filter type J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1688 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mavroudis and R. M. Sade The Southern Thoracic Surgical Association 50th anniversary celebration: the impact of STSA pediatric cardiothoracic surgery manuscripts on surgical practice Ann. Thorac. Surg., November 1, 2003; 76(90050): S47 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Gaynor Use of ultrafiltration during and after cardiopulmonary bypass in children J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(90030): S98 - 100. [Full Text] [PDF] |
||||
![]() |
I. Shen, C. Giacomuzzi, and R. M. Ungerleider Current strategies for optimizing the use of cardiopulmonary bypass in neonates and infants Ann. Thorac. Surg., February 1, 2003; 75(2): S729 - S734. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A Maluf Modified ultrafiltration in surgical correction of congenital heart disease with cardiopulmonary bypass Perfusion, January 1, 2003; 18(1_suppl): 61 - 68. [Abstract] [PDF] |
||||
![]() |
P. Tassani, A. Barankay, F. Haas, S. U. Paek, M. Heilmaier, J. Hess, R. Lange, and J. A. Richter Cardiac surgery with deep hypothermic circulatory arrest produces less systemic inflammatory response than low-flow cardiopulmonary bypass in newborns J. Thorac. Cardiovasc. Surg., April 1, 2002; 123(4): 648 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hiramatsu, Y. Imai, H. Kurosawa, Y. Takanashi, M. Aoki, T. Shin'oka, and M. Nakazawa Effects of dilutional and modified ultrafiltration in plasma endothelin-1 and pulmonary vascular resistance after the Fontan procedure Ann. Thorac. Surg., March 1, 2002; 73(3): 862 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Gaynor, N. D. Bridges, M. I. Cohen, W. T. Mahle, W. M. DeCampli, J. M. Steven, S. C. Nicolson, and T. L. Spray Predictors of outcome after the Fontan operation: Is hypoplastic left heart syndrome still a risk factor? J. Thorac. Cardiovasc. Surg., February 1, 2002; 123(2): 237 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Amin, D. B. McElhinney, J. K. Strawn, J. D. Kugler, K. F. Duncan, V. M. Reddy, E. Petrossian, and F. L. Hanley Hemidiaphragmatic paralysis increases postoperative morbidity after a modified Fontan operation J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 856 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Luciani, T. Menon, B. Vecchi, S. Auriemma, and A. Mazzucco Modified Ultrafiltration Reduces Morbidity After Adult Cardiac Operations: A Prospective, Randomized Clinical Trial Circulation, September 18, 2001; 104(2009): I-253 - I-259. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Gaynor Use of ultrafiltration during and after cardiopulmonary bypass in children J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 209 - 211. [Full Text] [PDF] |
||||
![]() |
L. D. Thompson, D. B. McElhinney, P. Findlay, W. Miller-Hance, M. J. Chen, M. Minami, E. Petrossian, A. J. Parry, V. M. Reddy, and F. L. Hanley A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in pediatric cardiac surgery J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 220 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R Glogowski, A. H Stammers, K. S Niimi, K. D Tremain, M. L Muhle, and C. C Trowbridge The effect of priming techniques of ultrafiltrators on blood rheology: an in vitro evaluation Perfusion, May 1, 2001; 16(3): 221 - 228. [Abstract] [PDF] |
||||
![]() |
S. T. Verghese Modified Ultrafiltration in Children Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2001; 5(1): 98 - 104. [Abstract] [PDF] |
||||
![]() |
U. Kiziltepe, A. Uysalel, T. Corapcioglu, K. Dalva, H. Akan, and H. Akalin Effects of combined conventional and modified ultrafiltration in adult patients Ann. Thorac. Surg., February 1, 2001; 71(2): 684 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Onoe, T. Magara, Y. Yamamoto, and T. Nojima Modified ultrafiltration removes serum interleukin-8 in adult cardiac surgery Perfusion, January 1, 2001; 16(1): 37 - 42. [Abstract] [PDF] |
||||
![]() |
M. I. Cohen, N. D. Bridges, J. W. Gaynor, T. M. Hoffman, G. Wernovsky, V. L. Vetter, T. L. Spray, and L. A. Rhodes Modifications to the cavopulmonary anastomosis do not eliminate early sinus node dysfunction J. Thorac. Cardiovasc. Surg., November 1, 2000; 120(5): 891 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wernovsky, K. M. Stiles, K. Gauvreau, T. L. Gentles, A. J. duPlessis, D. C. Bellinger, A. Z. Walsh, J. Burnett, R. A. Jonas, J. E. Mayer Jr, et al. Cognitive Development After the Fontan Operation Circulation, August 22, 2000; 102(8): 883 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Mosca, T. J. Kulik, C. S. Goldberg, R. P. Vermilion, J. R. Charpie, D. C. Crowley, and E. L. Bove EARLY RESULTS OF THE FONTAN PROCEDURE IN ONE HUNDRED CONSECUTIVE PATIENTS WITH HYPOPLASTIC LEFT HEART SYNDROME J. Thorac. Cardiovasc. Surg., June 1, 2000; 119(6): 1110 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Mahle, R. R. Clancy, E. M. Moss, M. Gerdes, D. R. Jobes, and G. Wernovsky Neurodevelopmental Outcome and Lifestyle Assessment in School-Aged and Adolescent Children With Hypoplastic Left Heart Syndrome Pediatrics, May 1, 2000; 105(5): 1082 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Mahle, G. Wernovsky, N. D. Bridges, A. B. Linton, and S. M. Paridon Impact of early ventricular unloading on exercise performance in preadolescents with single ventricle fontan physiology J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1637 - 1643. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Pearl, P. B. Manning, J. L. McNamara, M. M. Saucier, and D. W. Thomas Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass Ann. Thorac. Surg., October 1, 1999; 68(4): 1369 - 1375. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J Elliott Recent advances in paediatric cardiopulmonary bypass Perfusion, July 1, 1999; 14(4): 237 - 246. [PDF] |
||||
![]() |
R. R. Chaturvedi, D. F. Shore, P. A. White, M. H. Scallan, J. W. W. Gothard, A. N. Redington, and C. Lincoln Modified ultrafiltration improves global left ventricular systolic function after open-heart surgery in infants and children Eur J Cardiothorac Surg, June 1, 1999; 15(6): 742 - 746. [Full Text] [PDF] |
||||
![]() |
E. Petrossian, V. M. Reddy, D. B. McElhinney, G. P. Akkersdijk, P. Moore, A. J. Parry, L. D. Thompson, and F. L. Hanley EARLY RESULTS OF THE EXTRACARDIAC CONDUIT FONTAN OPERATION J. Thorac. Cardiovasc. Surg., April 1, 1999; 117(4): 688 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Hennein, U. Kiziltepe, S. Barst, K. A. Bocchieri, A. Hossain, D. R. Call, D. G. Remick, and J. P. Gold VENOVENOUS MODIFIED ULTRAFILTRATION AFTER CARDIOPULMONARY BYPASS IN CHILDREN: A PROSPECTIVE RANDOMIZED STUDY J. Thorac. Cardiovasc. Surg., March 1, 1999; 117(3): 496 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Gaynor, M. H. Collins, J. Rychik, J. P. Gaughan, and T. L. Spray LONG-TERM OUTCOME OF INFANTS WITH SINGLE VENTRICLE AND TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION J. Thorac. Cardiovasc. Surg., March 1, 1999; 117(3): 506 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Aeba, T. Matayoshi, T. Katogi, and S. Kawada Speed-controlled venovenous modified ultrafiltration for pediatric open heart operations Ann. Thorac. Surg., November 1, 1998; 66(5): 1835 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Gurbuz, W. M. Novick, C. A. Pierce, and D. C. Watson Impact of Ultrafiltration on Blood Use for Atrial Septal Defect Closure in Infants and Children Ann. Thorac. Surg., April 1, 1998; 65(4): 1105 - 1109. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |